Falconer Ester 4
4 · AbCellera Biologics Inc. · Filed Apr 23, 2021
Insider Transaction Report
Form 4
Falconer Ester
Chief Technology Officer
Transactions
- Exercise/Conversion
Share Option (right to buy)
2021-03-19−1,000,000→ 0 totalExercise: $0.03Exp: 2025-08-04→ Common Shares (1,000,000 underlying) - Exercise/Conversion
Common Shares
2021-03-19$0.03/sh+1,000,000$34,300→ 1,000,000 total
Footnotes (2)
- [F1]The exercise price reported above was converted from the Canadian exercise price of CAD $0.0450 using an exchange rate on August 4, 2015 of CAD $1.313 = US $1.00.
- [F2]As of the date of the transaction, the option was fully vested and exercisable.